相关实验视频

Updated: May 9, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

针对线粒体功能障碍:治疗纤维化的创新策略

Yi-Jin Wu¹, Yan-Rong Yang¹, Ya-Ling Yan¹

¹Department of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China.

Molecular and cellular biochemistry

|April 29, 2025

概括

线粒体功能障碍有助于病进展和纤维化. 了解这些机制可以帮助开发新的疗法来减缓损伤.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
细胞生物学细胞生物学
线粒体生物学线粒体生物学

背景情况:

病发病率,特别是末期病,在全球范围内正在上升.
线粒体功能障碍会损害细胞能量代谢,增加脏中的氧化应激.
线粒体质量控制对于预防纤维化 (RF) 是至关重要的.

研究的目的:

审查纤维化中线粒体损伤的分子机制.
探索线粒体功能障碍在射频病原发生中的作用.
为针对RF的新型治疗策略提供基础.

主要方法:

对现有文献进行系统审查.
阐述了链接线粒体功能障碍和RF的分子机制.
分析涉及RF的细胞过程,包括受体细胞损伤,细胞转差,纤维细胞激活和巨细胞透.

主要成果:

线粒体功能障碍是纤维化进展的关键因素.
线粒体动力学,自,氧化应激调节和生物合成的干扰与RF有关.
线粒体损伤在RF的多细胞病理过程中起着重要作用.

结论:

线粒体功能障碍对纤维化发展和进展至关重要.
准线粒体通路为脏疾病提供了潜在的治疗途径.
对线粒体机制的进一步研究可以导致推迟射频进步的策略.

关键词:

慢性脏疾病慢性脏疾病线粒体动力学的动态线粒体功能障碍线粒体功能障碍患有脏纤维化脏管状上皮细胞是脏管状上皮细胞.

更多相关视频

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...